SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors of the class action filed on behalf of all persons and entities that purchased or otherwise acquired Humacyte, Inc. (NASDAQ: HUMA) securities between May 10, 2024 and October 17, 2024. Humacyte and its consolidated subsidiaries develop and manufacture off-the-shelf, implantable, and bioengineered human tissues.
Press Release: Robbins LLP Urges HUMA Stockholders with Large Losses to Contact the Firm for Information About the Humacyte, Inc. Class Action Lawsuit - Newscast
Tue, 04 Feb 2025 17:51:00 GMT The complaint alleges that on October 31, 2024, ESSA issued a press release announcing its decision to terminate Phase 2 of the M-E Combination Study, citing "a protocol-specified interim review ...
Tue, 04 Feb 2025 16:00:00 GMT As news of this wrongdoing was revealed, the price of Croc's stock declined, harming investors. About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of ...
Tue, 04 Feb 2025 00:44:00 GMT SAN DIEGO, Feb. 4, 2025 /PRNewswire/ -- Robbins LLP reminds investors that ... The complaint alleges that on October 31, 2024, ESSA issued a press release announcing its decision to terminate ...
